Teva Earnings Miss Estimates. The Stock Is Falling.

1 month ago 14
PR Distribution

This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn

Updated Oct. 27, 2021 10:58 americium ET / Original Oct. 27, 2021 8:49 americium ET

  • Order Reprints
  • Print Article

Teva Pharmaceutical was falling aft the Israeli generics drugs institution missed quarterly net forecasts owed to weakness successful its U.S. generics business.

The banal roseate soon aft the markets opened Wednesday but was falling precocious by 4.47% to $8.97. The banal has fallen astir 7.5% twelvemonth to date.

Adjusted third-quarter net were 59...

Read Entire Article